Videos

Ending the Echo: the Partnership for Vivax Elimination

Screenshot from the video. © Medicines for Malaria Venture (MMV)

Plasmodium vivax malaria can lead to repeated bouts of illness, causing fever, weakness, and repeated setbacks for communities. Unlike other forms of malaria, P. vivax can hide in the liver and re-emerge multiple times, making it particularly difficult to treat.

“Ending the Echo” follows the Partnership for Vivax Elimination (PAVE) as it works to break this cycle. Filmed across Ethiopia, Indonesia, Papua New Guinea, Peru and Vietnam, the video highlights PAVE’s real-world studies on innovative tools that could transform P. vivax care. By evaluating point-of-care G6PD testing alongside single-dose tafenoquine and shorter-course, higher-dose primaquine, PAVE is helping make the radical cure safer and more accessible – with the potential to prevent relapses and strengthen care for vulnerable communities. Through testimonies from health workers, researchers and communities, the video illustrates what it takes to introduce new tools in diverse settings, and how stronger, more responsive health systems can change lives. Supported by Unitaid, this work is generating the evidence needed for national policy change and global uptake, paving the way toward ending P. vivax malaria.